It is possible that in CML, the differential positioning of telomeres may be a consequence of BCR::ABL1 activity, additional chromosomal abnormalities, as seen in different stages of the disease, and gene expression. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.